Expert Interview
Dissecting the results from the SURMOUNT-4 clinical trial regarding weight gain after the discontinuation of Zepbound (tirzepatide).
Ticker(s): LLYInstitution: Emory Healthcare
- Chief Medical Officer, Chief Quality & Patient Safety Officer, and Professor of Medicine at Emory Healthcare.
- Maintains a largely administrative role and manages several patients for obesity and diabetes.
- Discusses drug coverage with insurance providers on a regular basis.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
